EPISODE · Mar 11, 2024 · 17 MIN
Immunotherapy Part 3: Common Controversies and Remaining Questions
from SGO on the GO · host The Society of Gynecologic Oncology
This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology - VCU Health Massey Cancer CenterSarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center
What this episode covers
This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of Pharmacy C...
NOW PLAYING
Immunotherapy Part 3: Common Controversies and Remaining Questions
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m